Protein & Cell >

2018 , Vol. 9 >Issue 3: 239 - 240

DOI: https://doi.org/10.1007/s13238-017-0493-4

COMMENTARY

Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity

  • Diane DiEuliis 1 ,
  • James Giordano , 2
Expand
  • 1. Center for the Study of Weapons of Mass Destruction, National Defense University, Washington, DC 20057, USA
  • 2. Departments of Neurology and Biochemistry and Neuroethics Studies Program-Pellegrino Center for Clinical Bioethics, Georgetown University Medical Center, Washington, DC 20057, USA

Published date: 25 Mar 2018

Copyright

2017 The Author(s) 2017. This article is an open access publication
Fold

Cite this article

Diane DiEuliis , James Giordano . Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity[J]. Protein & Cell, 2018 , 9(3) : 239 -240 . DOI: 10.1007/s13238-017-0493-4

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Clapper J (2016) Director of National Intelligence Statement for the Record, Worldwide Threat Assessment of the US Intelligence Community Senate Armed Services Committee.<Date>9 Feb 2016</Date>

2
DiEuliis D, Giordano J (2017) Why gene editors like CRISPR/Cas9 may be a game-changer for neuroweapons. Health Secur 15(3):296–302

DOI

3
Gerstein D, Giordano J (2017) Re-thinking the biological toxin and weapons convention? Health Secur 15(6):1–3

DOI

4
Giordano J (2016) The neuroweapons threat. Bull Atomic Sci 72(3):1–4

5
Giordano J (2017) Battlescape brain: engaging neuroscience in defense operations. HDIAC J 3(4):13–16

6
Industry Association of Synthetic Biology (IASB) code of conduct for best practices in gene synthesis; https://repository.library.georgetown.edu/handle/10822/515024 . Accessed <Date>20 Oct 2017</Date>

7
Kang XJ, Caparas CIN, Soh BS, Fan Y (2017) Addressing challenges in the clinical applications associated with CRISPR/Cas9 technology and ethical questions to prevent its misuse. Protein Cell 8:791–795

DOI

8
Lanzilao E, Shook J, Benedikter R, Giordano J (2013) Advancing neuroscience on the 21st century world stage: the need for—and proposed structure of—an internationally relevant neuroethics. Ethics Biol Eng Med 4(3):211–229

DOI

9
Mullin E (2017) Five ways to get CRISPR into the body. MIT Technology Review. https://www.technologyreview.com/s/608898/five-ways-to-get-crispr-into-the-body/. Accessed <Date>Sept 2017</Date>

10
National Academies of Sciences, Engineering, and Medicine (2017) Preparing for Future Products of Biotechnology. Washington, DC: The National Academies Press. https://doi.org/10.17226/24605

DOI

11
Palchik G, Chen C, Giordano J (2017) Monkey business? Development, influence and ethics of potentially dual-use brain science on the world stage. Neuroethics 10:1–4

12
Protecting financial data in cyberspace, Carnegie Endowment. http://carnegieendowment.org/2017/08/24/protecting-financialdata-in-cyberspace-precedent-for-further-progress-on-cybernorms-pub-72907; Accessed <Date>21 Oct 2017</Date>

13
Scheufele(2017) U.S. attitudes on human genome editing. Science 357:6351

DOI

14
Talinn Manual, NATO. https://ccdcoe.org/research.html. Accessed <Date>20 Oct 2017</Date>

Options
Outlines

/

〈 〉